Regucalcin

From WikiMD's Medical Encyclopedia

Regucalcin (Japanese: レグカルシン), also known as Senescence Marker Protein-30 (SMP30), is a protein that in humans is encoded by the RGN gene. Regucalcin plays a crucial role in calcium signaling within cells, particularly in maintaining calcium homeostasis. It is widely expressed in various tissues, including the liver, kidney, heart, and brain, and has been implicated in a range of physiological and pathological processes.

Function[edit]

Regucalcin has a pivotal role in regulating intracellular calcium levels, which is vital for various cellular functions such as enzyme activities, gene expression, and cell proliferation. It acts by inhibiting the influx of calcium into cells and by modulating the activity of calcium pumps, which helps in reducing cytoplasmic calcium concentration. Additionally, regucalcin is involved in the suppression of apoptosis (programmed cell death), antioxidative responses, and the regulation of liver and kidney function.

Clinical Significance[edit]

The expression of regucalcin has been shown to decrease with age, linking it to age-related diseases. Its reduced levels have been associated with the pathogenesis of osteoporosis, due to its role in calcium homeostasis, and potentially with the development of certain types of cancer. Moreover, regucalcin plays a role in protecting cells against oxidative stress, suggesting its involvement in the prevention of diseases related to oxidative damage, such as cardiovascular diseases and neurodegenerative diseases.

Genetic Aspects[edit]

The RGN gene encoding regucalcin is located on chromosome 7 in humans. Variations in this gene may influence the expression or function of regucalcin, potentially affecting an individual's susceptibility to diseases related to calcium dysregulation.

Research Directions[edit]

Ongoing research is focused on elucidating the detailed mechanisms by which regucalcin regulates calcium homeostasis and its broader implications in health and disease. Studies are also exploring the potential of regucalcin as a therapeutic target for diseases associated with calcium imbalance and oxidative stress.

See Also[edit]

References[edit]

<references/>

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.